Synergistic Activity Between Triphala and Selected Antibiotics Against Drug Resistant Clinical Isolates

Overview

Journal BMC Complement Altern Med

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2019 Aug 4

PMID 31375093

Citations 5

Authors

Amirthasingam Manoraj

Vasanthi Thevanesam

B M R Bandara

Asela Ekanayake

Veranja Liyanapathirana

Affiliations

Soon will be listed here.

Abstract

Background: Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms.

Methods: The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetrazolium chloride (TTC) assay. Fractional inhibitory concentration (FIC) index was calculated.

Results: When tested alone, the minimum inhibitory concentration (MIC) values of gentamicin for Gram negative isolates ranged from 8 to > 64 μg/ml. The MIC values of gentamicin for the Gram negative isolates ranged from 1 to 32 μg/ml when tested with Triphala. The FIC index was < 1 indicating a synergistic interaction in 10 of the 11 isolates and it was 1 indicating an additive effect in one isolate. The MIC values of oxacillin for MRSA isolates ranged from 4 to > 16 μg/ml with all MICs being equal to or higher than the resistance cut-off level. The MIC level with the addition of Triphala ranged from 0.25 to 4 μg/ml. FIC index was < 1 for all tested isolates indicating a synergistic interaction.

Conclusions: Triphala has synergistic activity with gentamicin against the selected MDR Gram negative bacilli and with oxacillin against MRSA isolates warranting further studies on the possibility of clinical use.

Citing Articles

Antibiotic potentiating effect of L. against multidrug resistant .

Limboo K, Singh B Front Microbiol. 2024; 15:1385268.

PMID: 38694794 PMC: 11062131. DOI: 10.3389/fmicb.2024.1385268.

Inhibitory effects of Triphala on CYP isoforms and its pharmacokinetic interactions with phenacetin and midazolam in rats.

Nontakham J, Siripong P, Sato H, Chewchinda S, Arunrungvichian K, Yahuafai J Heliyon. 2022; 8(6):e09764.

PMID: 35785236 PMC: 9243172. DOI: 10.1016/j.heliyon.2022.e09764.

Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics.

Wang N, Luo J, Deng F, Huang Y, Zhou H Front Pharmacol. 2022; 13:839808.

PMID: 35281905 PMC: 8905495. DOI: 10.3389/fphar.2022.839808.

Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review.

Phimarn W, Sungthong B, Itabe H J Evid Based Integr Med. 2021; 26:2515690X211011038.

PMID: 33886393 PMC: 8072855. DOI: 10.1177/2515690X211011038.

Investigation of the Interaction of Herbal Ingredients Contained in Triphala Recipe Using Simplex Lattice Design: Chemical Analysis Point of View.

Monton C, Wunnakup T, Suksaeree J, Charoenchai L, Chankana N Int J Food Sci. 2020; 2020:5104624.

PMID: 32832540 PMC: 7424382. DOI: 10.1155/2020/5104624.

References

te Dorsthorst D, Verweij P, Meis J, Punt N, Mouton J . Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother. 2002; 46(3):702-7. PMC: 127491. DOI: 10.1128/AAC.46.3.702-707.2002. View

Stapleton P, Taylor P . Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog. 2002; 85(Pt 1):57-72. PMC: 2065735. DOI: 10.3184/003685002783238870. View

Bonapace C, Bosso J, Friedrich L, White R . Comparison of methods of interpretation of checkerboard synergy testing. Diagn Microbiol Infect Dis. 2003; 44(4):363-6. DOI: 10.1016/s0732-8893(02)00473-x. View

Srikumar R, Parthasarathy N, Shankar E, Manikandan S, Vijayakumar R, Thangaraj R . Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother Res. 2007; 21(5):476-80. DOI: 10.1002/ptr.2105. View

Leibovici L, Vidal L, Paul M . Aminoglycoside drugs in clinical practice: an evidence-based approach. J Antimicrob Chemother. 2008; 63(2):246-51. DOI: 10.1093/jac/dkn469. View

Kumar M, Kirubanandan S, Sripriya R, Sehgal P . Triphala incorporated collagen sponge--a smart biomaterial for infected dermal wound healing. J Surg Res. 2009; 158(1):162-70. DOI: 10.1016/j.jss.2008.07.006. View

Prabhakar J, Senthilkumar M, Priya M, Mahalakshmi K, Sehgal P, Sukumaran V . Evaluation of antimicrobial efficacy of herbal alternatives (Triphala and green tea polyphenols), MTAD, and 5% sodium hypochlorite against Enterococcus faecalis biofilm formed on tooth substrate: an in vitro study. J Endod. 2009; 36(1):83-6. DOI: 10.1016/j.joen.2009.09.040. View

Hazra B, Sarkar R, Biswas S, Mandal N . Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010; 10:20. PMC: 2887379. DOI: 10.1186/1472-6882-10-20. View

Bajaj N, Tandon S . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. Int J Ayurveda Res. 2011; 2(1):29-36. PMC: 3157106. DOI: 10.4103/0974-7788.83188. View

10.

Tambekar D, Dahikar S . Antibacterial activity of some Indian Ayurvedic preparations against enteric bacterial pathogens. J Adv Pharm Technol Res. 2011; 2(1):24-9. PMC: 3217688. DOI: 10.4103/2231-4040.79801. View

11.

Phatthalung P, Chusri S, Voravuthikunchai S . Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections. BMC Complement Altern Med. 2012; 12:56. PMC: 3416686. DOI: 10.1186/1472-6882-12-56. View

12.

Baliga M, Meera S, Mathai B, Rai M, Pawar V, Palatty P . Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review. Chin J Integr Med. 2012; 18(12):946-54. DOI: 10.1007/s11655-012-1299-x. View

13.

Bag A, Bhattacharyya S, Pal N . Antibacterial potential of hydroalcoholic extracts of triphala components against multidrug-resistant uropathogenic bacteria--a preliminary report. Indian J Exp Biol. 2014; 51(9):709-14. View

14.

Baskaran U, Martin S, MahaboobKhan R, Prince S . Protective role of Triphala, an Indian traditional herbal formulation, against the nephrotoxic effects of bromobenzene in Wistar albino rats. J Integr Med. 2015; 13(2):115-21. DOI: 10.1016/S2095-4964(15)60165-0. View

15.

Akarshini A, Aruna . Management of Madhumeha Janya Upadrava with special reference to diabetic nephropathy - A clinical study. Ayu. 2015; 35(4):378-83. PMC: 4492021. DOI: 10.4103/0974-8520.158987. View

16.

Teka A, Rondevaldova J, Asfaw Z, Demissew S, Van Damme P, Kokoska L . In vitro antimicrobial activity of plants used in traditional medicine in Gurage and Silti Zones, south central Ethiopia. BMC Complement Altern Med. 2015; 15:286. PMC: 4539890. DOI: 10.1186/s12906-015-0822-1. View

17.

Basri D, Sandra V . Synergistic Interaction of Methanol Extract from Canarium odontophyllum Miq. Leaf in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 33591. Int J Microbiol. 2016; 2016:5249534. PMC: 4781960. DOI: 10.1155/2016/5249534. View

18.

Kesharwani A, Polachira S, Nair R, Agarwal A, Mishra N, Gupta S . Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med. 2017; 17(1):110. PMC: 5310005. DOI: 10.1186/s12906-017-1620-8. View

19.

Sanhueza L, Melo R, Montero R, Maisey K, Mendoza L, Wilkens M . Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. PLoS One. 2017; 12(2):e0172273. PMC: 5325233. DOI: 10.1371/journal.pone.0172273. View

20.

Hall M, Middleton R, Westmacott D . The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother. 1983; 11(5):427-33. DOI: 10.1093/jac/11.5.427. View